Skip to main content

Table 3 short- and long-term morbidity

From: Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort treated for Cushing’s disease: surgical outcome, mortality, and complications

 

Hazard ratio (95% CI; p-value)#, unadjusted

Hazard ratio (95% CI; p-value)#, adjusted for age at diagnosis and tumor size (microadenoma or macroadenoma)

Surgical outcome

-Persistent disease

0.82 (0.34 to 2.01; p = 0.663)

0.88 (0.35 to 2.21; p = 0.789)

-Recurrent disease

0.47 (0.19 to 1.14; p = 0.093)

0.40 (0.16 to 1.01; p = 0.052)

-Hydrocortisone dependency

- Absolute deficiency

- Normal cortisol response*

- Pragmatic replacement $

1.11 (0.73 to 1.68; p = 0.625)

1.06 (0.69 to 1.62; p = 0.793)

1.04 (0.68 to 1.60; p = 0.845)

0.97 (0.63 to 1.50; p = 0.888)

-Repeat surgery

-Remission after first repeat surgery

0.30 (0.13 to 0.70; p = 0.005)

0.21 (0.04 to 1.13; p = 0.069)

0.27 (0.11 to 0.64; p = 0.003)

0.17 (0.02 to 1.16; p = 0.070)

Short term morbidity: ≤3 month after first surgery

-Cerebrospinal fluid leakage

°

°

-Meningitis

°

°

-Bleeding, all

0.56 (0.22 to 1.41; p = 0.221)

0.56 (0.22 to 1.44; p = 0.227)

-Bleeding, severe

°

°

-Syndrome of inappropriate antidiuretic hormone release

0.32 (0.09 to 1.09; p = 0.069)

0.29 (0.08 to 1.02; p = 0.054)a

-Diabetes insipidus

1.04 (0.54 to 1.99; p = 0.904)

0.96 (0.49 to 1.86; p = 0.901)

-Anterior pituitary deficiency

- one axis

- two axes

- three axes

0.76 (0.37 to 1.54; p = 0.444)

0.85 (0.37 to 1.96; p = 0.704)

0.41 (0.09 to 1.83; p = 0.243)

1.06 (0.51 to 2.22; p = 0.870)

1.18 (0.50 to 2.79; p = 0.708)

0.52 (0.11 to 2.45; p = 0.409)

-Corticosteroid withdrawal syndrome

0.39 (0.21 to 0.72; p = 0.003)

0.38 (0.20 to 0.72; p = 0.003)

-Cardiovascular morbidity

°

°

Long term morbidity: > 3 months after first surgery

-Anterior pituitary deficiency after 1 year

- one axis

- two axes

- three axes

0.79 (0.42 to 1.52; p = 0.488)

0.83 (0.38 to 1.83; p = 0.642)

0.65 (0.17 to 2.41; p = 0.517)

1.03 (0.52 to 2.01; p = 0.056)

1.10 (0.48 to 2.48; p = 0.827)

0.74 (0.19 to 2.89; p = 0.663)

-Hydrocortisone dependency > 3 years

1.05 (0.56 to 1.96; p = 0.878)

1.11 (0.59 to 2.10; p = 0.742)

-Diabetes insipidus > 3 months

1.71 (0.68 to 4.29; p = 0.251)

1.84 (0.72 to 4.69; p = 0.204)

-Cardiovascular morbidity

0.37 (0.12 to 1.16; p = 0.088)

0.43 (0.13 to 1.38; p = 0.155)

-Hypertension

0.85 (0.51 to 1.41; p = 0.529)

0.92 (0.53 to 1.58; p = 0.749)

-Diabetes mellitus

0.53 (0.22 to 1.29; p = 0.160)

0.56 (0.23 to 1.36; p = 0.198)

-Neuropsychiatric morbidity

0.14 (0.03 to 0.68; p = 0.015)

0.15 (0.03 to 0.76; p = 0.022)

  1. CI = confidence interval
  2. #Reference group for hazard ratios was endoscopic surgery
  3. aAdjusted for age at diagnosis only
  4. *Hydrocortisone for symptoms despite normal cortisol response to CRH stimulation. °Insufficient data for analysis
  5. $Pragmatic hydrocortisone replacement (without stimulation test)